Heads up: some links below are affiliate links — assume any provider we list may compensate us, at no cost to you. It never buys a better score, but the providers we work with are listed first. See our affiliate disclosure.
Vyvron review
The billing cycle is stated in the same sentence as the price, so the year is countable without guesswork: thirteen charges of $149 is $1,937 for semaglutide and $2,587 for tirzepatide. Both are founding rates the site says will rise to $179 and $249 — $2,327 and $3,237 a year. What you cannot read is any of its legal documents, because they are the homepage with a different title on the tab.
- HSA / FSA-eligible
- Editor-vetted
- No insurance needed
Vyvron at a glance
- Semaglutide
- $149 per 4 weeks
- Tirzepatide
- $199 per 4 weeks
- Coverage
- Not published
- Start
- Days after the online evaluation
How we scored Vyvron
Each factor is read off Vyvron's published pricing, disclosures and intake flow, and the six roll up into the 49/100 Rx-Readiness Score on the same weighted six-factor framework we apply to every provider — never nudged by whether a provider pays us.
Tiered or opaque — the true monthly is hard to pin down up front.
Limited or state-gated availability — confirm yours first.
Not a two-molecule plan on the published facts — switching may mean starting again elsewhere.
Exit terms are the weak point: lock-in, notice periods, or a cancellation path that isn't published.
The hardest start to fit around a workday — a scheduled visit, or no published answer either way.
The weakest showing on speed — a slow published timeline, or none at all.
How we verified this review
- Last verified
- August 2026
- Confidence
- medium
- Primary source
- vyvron.com
Checked on 18 August 2026. Vyvron LLC charges $149 for compounded semaglutide and $199 for tirzepatide, and states the billing period alongside: "per 4 weeks, billed every 4 weeks; auto-renews until you cancel". That makes the year countable — thirteen charges, so $1,937 and $2,587 at these rates, or $2,327 and $3,237 once the founding prices return to $179 and $249 as the site says they will. A four-week cycle is 8% more than a monthly reading of the same number. It carries a LegitScript badge and states there are no hidden fees and cancellation is available at any time. Against that, its legal pages do not exist: /terms, /privacy, /privacy-policy and /shipping-policy each return the homepage under a legal-sounding title, at 0.993 to 0.995 similarity — close but never identical, so only a proper comparison catches it. Its scarcity counter still reads "100 of 100 founding spots left" on both products. No state list, no compounding pharmacy, and clean against the live FDA warning-letter index.
Pricing
Prices re-verified
| Medication | Monthly | Plan |
|---|---|---|
| Compounded semaglutidePer 4 weeks, auto-renewing"$149 per 4 weeks, billed every 4 weeks; auto-renews until you cancel" — the founding rate. The site says the price returns to $179. Thirteen charges a year, not twelve. | $149 | Per 4 weeks, auto-renewing"$149 per 4 weeks, billed every 4 weeks; auto-renews until you cancel" — the founding rate. The site says the price returns to $179. Thirteen charges a year, not twelve. |
| Compounded tirzepatidePer 4 weeks, auto-renewing"$199 per 4 weeks" at the founding rate, returning to $249. Same four-week cycle, stated in the same sentence as the price. | $199 | Per 4 weeks, auto-renewing"$199 per 4 weeks" at the founding rate, returning to $249. Same four-week cycle, stated in the same sentence as the price. |
HSA/FSA generally applies to GLP-1 telehealth; confirm with your plan. These figures are Vyvron's public disclosures at last review and change often; confirm the current number on Vyvron's own site.
What we like
- States the four-week cycle beside the price, so thirteen charges a year is obvious rather than discovered
- Discloses auto-renewal in the same sentence
- Both molecules priced separately at $149 and $199 per four weeks
- Vyvron LLC is named and a LegitScript badge is displayed
- "No hidden fees · Cancel anytime · Provider-guided" on both products
The caveats
- Terms, privacy and shipping policy do not exist — each URL returns the homepage under a legal title
- Thirteen charges a year is 8% more than a monthly reading of the same figure
- Both rates are founding prices the site says will rise
- "100 of 100 founding spots left", unchanged, on both products
- No state list
- No compounding pharmacy named
Vyvron for working moms: our verdict
The billing cycle is stated in the same sentence as the price, so the year is countable without guesswork: thirteen charges of $149 is $1,937 for semaglutide and $2,587 for tirzepatide. Both are founding rates the site says will rise to $179 and $249 — $2,327 and $3,237 a year. What you cannot read is any of its legal documents, because they are the homepage with a different title on the tab. It runs about $149/4 weeks — toward the affordable end of what we track.
We weigh Vyvron the way working moms actually have to: not just the monthly line on your budget, but how fast you can start without a scheduled video visit and a flat monthly price that doesn't climb as your dose does — the parts a generic review does not measure.
What Vyvron will cost you
- Compounded semaglutide — Per 4 weeks, auto-renewing: $149/4 wks
- Compounded tirzepatide — Per 4 weeks, auto-renewing: $199/4 wks
That sits below the roughly $179 median ongoing price across the providers we track for working moms — a real cost advantage.
The medications Vyvron prescribes
Vyvron prescribes semaglutide and tirzepatide — the two best-evidenced molecules in the class, and having both on one account matters because you can switch between them without re-enrolling or hunting down a new provider mid-plan. These are compounded formulations from a licensed pharmacy — the reason the price stays down — but compounded GLP-1s aren't FDA-approved finished products the way Wegovy and Zepbound are.
Where Vyvron fits — and where it doesn't — for working moms
Right for you if…
- the monthly line on your budget is a real barrier and you want a low, predictable number.
Not your best option if…
- you specifically want an FDA-approved brand pen and insurance navigation.
- you'd rather the most predictable place to start and pause — which is exactly what our #1 pick, CoreAge Rx, is designed around.
Trust, safety, and the fine print
Our confidence is moderate — the core facts check out, but some details (per-state availability, program mechanics) aren't fully public. As with any compounded GLP-1, the most useful thing working moms can do is confirm which licensed pharmacy fills the prescription and what's in the formulation — we explain how we weigh oversight in our scoring methodology.
A standing caveat for working moms: GLP-1 medications aren't established as safe during pregnancy or breastfeeding, and every label advises against use. Nothing here changes that — plan the timing with your own clinician.
The bottom line
Vyvron is a genuine value play — weigh it on how fast you can start without a scheduled video visit and a flat monthly price that doesn't climb as your dose does against the alternatives below. For most working moms, CoreAge Rx remains the stronger all-round fit — see why it tops our ranking.
The bottom line for working moms
Best for: A parent who wants the billing period stated so the annual figure is exact, and can accept a seller with no legal documents.
Alternatives to Vyvron
Providers we have a referral relationship with, ordered by Rx-Readiness Score — highest first. A fee never moves a score, but it does decide who appears here, so this is not the full list: see the complete ranking.
- Visit CoreAge RxRx-Readiness95100CoreAge RxOur #1 pick
The shortlist pick: one flat price that doesn't climb as your dose does, both molecules on a single plan, and a nationwide async intake you can finish on a break.
- Visit Pallas HealthRx-Readiness89100
Pallas Health removes the two things that usually cost a working parent the most time: it publishes every price before intake, and it runs care asynchronously in 43 of 50 states, so there's no video appointment to wedge into a workday. Compounded semaglutide averages about $199 a month and tirzepatide $299, and unusually the genuine FDA-approved pens sit alongside them — Zepbound $1,069, Ozempic $1,299, Wegovy and Mounjaro $1,349 — all cash-pay from the same clinician. The price is flat at every dose, so a titration never produces a surprise bill, and the plan figure already contains the clinician, dose adjustments, check-ins and messaging with no membership fee. Its cancellation terms are unusually concrete: cancel free through the portal, keep access to the end of the paid period, full refund if a clinician declines you, and a $5 processing fee on a qualifying refund. The trade-offs are that billing lands every 12 weeks in $597 and $897 blocks rather than monthly, the compounding pharmacy is never named, and insurance is never billed.
- Visit Trimi HealthRx-Readiness88100
The price-first partner: some of the lowest flat, all-inclusive compounded pricing we track, nationwide and async — strong if the monthly number is your deciding factor and you read the annual-prepay fine print.
Keep comparing Vyvron
Head-to-head & alternatives
Vyvron, answered
- How much does Vyvron cost?
- Budget around $149 a month — that was Vyvron's lowest ongoing compounded rate at last review ($149 per 4 weeks semaglutide, $199 per 4 weeks tirzepatide). Verify the all-in figure on their site before you plan around it; these numbers change often.
- Can I start Vyvron without a scheduled video visit?
- Vyvron involves more clinician touchpoints (and, in some cases, a scheduled visit), so it isn't the fastest async start. If a no-video signup is your priority, our #1 pick is built for it.
- Does Vyvron offer both semaglutide and tirzepatide?
- Yes — Vyvron offers both molecules, so you can switch without re-enrolling. Tirzepatide's dual GIP/GLP-1 action posts the strongest published weight-loss numbers.
- Where does Vyvron rank for working moms?
- Vyvron earns 49/100 on our Rx-Readiness Score, ranking #247. Speed to first dose and flat pricing carry the most weight of the six factors behind it. CoreAge Rx leads — see how they compare.
Pricing, states and verification reflect Vyvron's public disclosures at last review; the Rx-Readiness Score is our editorial judgment per the published methodology. This is background reading, not medical advice — GLP-1 medications are not established as safe in pregnancy or breastfeeding. See our medical disclaimer and how we're funded.